top of page

【Portfolio】维眸与贝达基金共建免疫创新药公司,启元生物正式启航

维眸-VVB logo.jpg

​​文章来源:维眸生物 http://www.vivavisionbio.com/

2020年12月11日

12月10日,致力于攻克自身免疫性疾病的生物科技公司--启元生物在杭州市余杭区举行了落户余杭暨贝达基金战略投资签约仪式。余杭区委常委、开发区党工委书记、管委会主任祝振伟,贝达药业董事长兼首席执行官、贝达基金创始人丁列明博士,启元生物董事长兼首席科学家沈旺博士等出席仪式。

启元生物由维眸生物与贝达基金共同合作组建,核心团队由资深科学家沈旺博士领衔,多位具有丰富临床开发和商业化经验的海归博士组成。公司拥有多个自主研发的创新药物,研发管线中QY201临床申报在即。近日,公司获得贝达基金数千万元天使轮投资。

余杭区委常委、开发区党工委书记、管委会主任祝振伟先生对启元生物落户余杭经济技术开发区表示欢迎。他说,启元生物由海外高层次人才沈旺博士领衔,是一家极具发展潜力的医药创新公司,将为开发区的高质量发展注入强劲动力。未来,余杭经济技术开发区将不断优化辖区内营商环境,激发市场主体活力,为企业创新、人才引进等提供最大力度的支持。祝愿启元生物如同“启明星”一般,在未来的发展道路上熠熠生辉。

贝达药业董事长兼首席执行官、贝达基金创始人丁列明博士在会上致欢迎词。他指出,这些年来,贝达药业在加快自身发展的同时,也在努力帮助优质创新项目实现产业化。启元生物专注于自身免疫性疾病新药研发,发展前景好、发展潜力大。未来,贝达药业、贝达基金将全力以赴支持启元生物的发展,助力启元生物发展成为优秀的医药创新企业。

启元生物董事长兼首席科学家沈旺博士在致辞时表示,余杭经济技术开发区是一片创新创业的沃土,很荣幸启元生物能成功落户在此地。同时,感谢贝达基金对启元生物的支持。作为生物医药行业的新生力量,启元生物将以贝达药业为榜样,扎根余杭,努力将公司建设好、运营好,助力余杭经济技术开发区高质量发展,为余杭区生物医药产业发展作出贡献。

会上,余杭开发区党工委委员、管委会副主任施科琦先生,启元生物董事长兼首席科学家沈旺博士代表双方进行落户签约仪式。

启元生物董事长兼首席科学家沈旺博士、贝达药业副总裁兼首席财务官范建勋先生分别代表启元生物与贝达基金进行战略投资签约仪式。

This website is for informational purposes only and does not constitute an offer to sell, a solicitation to buy, or a recommendation for any security; nor does it constitute an offer to provide investment advisory or other services by Viva Ventures Biotech Fund or any of our affiliates. Nothing contained on the website constitutes investment advice or offers any opinion with respect to the suitability of any security, and the views expressed on this website should not be taken as advice to buy, sell, or hold any security or as an endorsement of any security or company. In preparing the information contained in this website, Viva Ventures Biotech has not taken into account the investment needs, objectives, and financial circumstances of any particular investor, and investments and companies referenced may not be suitable for all investors. Any views expressed on this website by Viva Ventures biotech were prepared based upon information, believed to be reliable, available to it at the time such views were written. Viva Ventures Biotech makes no guarantees as to their accuracy or completeness. All information is subject to change and may quickly become unreliable for various reasons, including changes in market conditions or economic circumstances. By accessing this website, the reader agrees that he/she not copy, reproduce, republish, upload, post, transmit, alter, or distribute in any way material from this website in any manner inconsistent with the purposes for which it is offered without the prior written consent of Viva Ventures Biotech.

bottom of page